https://www.selleckchem.com/pr....oducts/Rosuvastatin-
A total of 33.3% of these participants had improved the mean UtA-PI at the 2 and 3 trimesters of gestation, although it was not statistically significant ( = 0.154). The prevalence ratio was 0.95 (95% confidence interval [CI] 0.31-1.89), but between the 1 and 2 trimesters of gestation, the PR was 0.92 (95%CI 0.21-0.99) and it was statistically significant. The present work demonstrates a modification of the mean UtA-PI in participants who took ASA compared with those who did not. It is important to check if ASA c
Like
Comment
Share
